Rockville, MD—Recent discoveries by researchers at the Uniformed Services University of the Health Sciences (USU) could lead to new avenues of exploration for radioprotection in diverse settings.

Silo Pharma, Inc. has announced the filing of a patent application for its neurology drug, SPC-14, which is an intranasal treatment for Alzheimer's disease. This compound, licensed from Columbia ...